Evidence map›Paper›PMID 37503297›Full record

ArticleResearch square2023

Phenotypic Correlates of Structural and Functional Protein Impairments Resultant from ALDH5A1 Variants.

Itay Tokatly Latzer, Jean-Baptiste Roullet, Samuele Cesaro, Melissa L DiBacco, Erland Arning, Alexander Rotenberg, Henry H C Lee, Thomas Opladen, Kathrin Jeltsch, Àngels García-Cazorla and 4 more

Abstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Itay Tokatly LatzerBoston Children's Hospital, Harvard Medical School.
Jean-Baptiste RoulletWashington State University.
Samuele CesaroUniversity of Verona.
Melissa L DiBaccoBoston Children's Hospital, Harvard Medical School.
Erland ArningBaylor Scott & White Research Institute.
Alexander RotenbergBoston Children's Hospital, Harvard Medical School.
Henry H C LeeBoston Children's Hospital, Harvard Medical School.
Thomas OpladenUniversity Children's Hospital Heidelberg.
Kathrin JeltschUniversity Children's Hospital Heidelberg.
Àngels García-CazorlaInstitut de Recerca, Hospital Sant Joan de Déu.
Natalia Juliá-PalaciosInstitut de Recerca, Hospital Sant Joan de Déu.
K Michael GibsonWashington State University.
Mariarita BertoldiUniversity of Verona.
Phillip L PearlBoston Children's Hospital, Harvard Medical School.

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Natural History of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD), a Heritable Disorder of GABA MetabolismR01HD091142 · NICHD · WASHINGTON STATE UNIVERSITY · PI Phillip Lawrence Pearl · 2018 to 2026
$5.3M
NICHD NIH HHS P50 HD105351NICHD NIH HHS R01 HD091142
6 · The paper itself

Abstract

Objective: To investigate the genotype-to-protein-to-phenotype correlations of succinic semialdehyde dehydrogenase deficiency (SSADHD), an inherited metabolic disorder of γ-aminobutyric acid catabolism. Methods: Bioinformatics and in silico mutagenesis analyses of ALDH5A1 variants were performed to evaluate their impact on protein stability, active site and co-factor binding domains, splicing, and homotetramer formation. Protein abnormalities were then correlated with a validated disease-specific clinical severity score and neurological, neuropsychological, biochemical, neuroimaging, and neurophysiological metrics. Results: A total of 58 individuals (1:1 male/female ratio) were affected by 32 ALDH5A1 pathogenic variants, eight of which were novel. Compared to individuals with single homotetrameric or multiple homo and heterotetrameric proteins, those predicted not to synthesize any functional enzyme protein had significantly lower expression of Conclusions: The quantity and type of enzyme proteins (no protein, single homotetramers, or multiple homo and heterotetramers), as well as their structural and functional impairments (catalytic or stability, folding, or oligomerization), contribute to phenotype severity in SSADHD. These findings are valuable for assessment of disease prognosis and management, including patient selection for gene replacement therapy. Furthermore, they provide a roadmap to determine genotype-to-protein-to-phenotype relationships in other autosomal recessive disorders.

Indexed as

4-hydroxybutyricuriagenotype-phenotypein-silicoSSADH Deficiencyvariants

Identifiers

PMID37503297
PMCPMC10371128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.